Questions
ghk cu dosage for wound healing: Frequently asked questions
Source-derived answers connected to this topic. Only stored records are displayed.
What If the Peptide Solution Turned Slightly Blue-Green After Reconstitution?
Discard it immediately. Color change indicates copper oxidation and peptide degradation. GHK-Cu in solution should remain clear to pale yellow. Blue-green discoloration means the copper ion dissociated from the peptide and formed insoluble copper hydroxide, rendering the compound biologically inactive. This happens when reconstitution water pH drifts above 7.4 or when the vial experiences temperature excursions above 25°C before mixing. Store lyophilized powder at -20°C and reconstituted solution at 2–8°C to prevent this.
What If the Wound Isn't Improving After 10 Days at Standard Dosing?
Increase dose from 1.5mg to 2.5mg daily and switch from topical to subcutaneous administration if you haven't already. Non-response after 10 days suggests either insufficient bioavailability (common with topical-only protocols on exudative wounds) or underlying factors like infection, poor vascular perfusion, or continued mechanical trauma that peptide therapy alone can't overcome. If wound cultures are negative and blood flow is adequate, the issue is likely enzymatic degradation. Chronic wounds produce 3–5× normal MMP levels that cleave GHK-Cu within hours of application.
What If I'm Administering GHK-Cu Topically But the Wound Bed Is Heavily Exudative?
Switch to subcutaneous injection 3–5mm from the wound margin instead of topical application. Wound exudate dilutes topical peptide concentration by 60–80% within the first hour, and the high protease content degrades what remains. Subcutaneous delivery bypasses dilution entirely and delivers concentrated peptide directly to the granulation tissue bed where fibroblasts are actively synthesizing collagen. This route also eliminates the need to reapply after every dressing change.
What If I Apply GHK-Cu to an Infected Wound?
Stop peptide application until the infection is cleared with appropriate antimicrobials. GHK-Cu's copper component can promote bacterial growth in actively infected tissue. Copper ions serve as cofactors for certain bacterial enzymes. The peptide shows antimicrobial properties against some species (notably Staphylococcus epidermidis), but shouldn't replace systemic or topical antibiotics in clinically infected wounds. Resume GHK-Cu once wound cultures are negative or clinical signs of infection (purulent drainage, expanding erythema, fever) have resolved.
What If I Miss Several Days of Application During the Critical Phase?
Resume at the concentration appropriate for the current healing phase, not the original protocol start point. If you miss days 3–6 (late inflammatory, early proliferative), restart at 500 µg/mL once daily rather than returning to 1 mg/mL twice daily. The wound has progressed beyond the debris-clearance phase even if delayed. Missing applications during days 7–14 (peak collagen deposition) has the most significant impact on final scar quality. If you miss this window, extend the remodelling phase dosing (200 µg/mL) through day 60 rather than stopping at day 45.
What If Higher Concentrations Aren't Producing Faster Healing?
Reassess wound bed preparation and underlying pathology before increasing peptide dose further. GHK-Cu efficacy plateaus above 5 mg/mL. Additional peptide doesn't accelerate healing. Stalled wounds despite appropriate dosing suggest non-peptide barriers: inadequate debridement leaving necrotic tissue that blocks peptide penetration, uncontrolled diabetes (HbA1c > 8%) impairing cellular response to growth signals, or arterial insufficiency limiting oxygen delivery below the threshold for collagen synthesis (transcutaneous oxygen < 30 mmHg). Address the systemic or mechanical barrier first.